1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
(
- Contribution to journal › Letter
- 2019
-
Mark
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine : 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial
(
- Contribution to journal › Article